4//SEC Filing
Czuczman Myron 4
Accession 0001213900-24-069249
CIK 0001851484other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 6:28 PM ET
Size
5.9 KB
Accession
0001213900-24-069249
Insider Transaction Report
Form 4
Czuczman Myron
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-12+466,667→ 466,667 totalExercise: $2.15Exp: 2033-07-05→ Common Stock (466,667 underlying)
Footnotes (1)
- [F1]This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.
Documents
Issuer
CITIUS ONCOLOGY, INC.
CIK 0001851484
Entity typeother
Related Parties
1- filerCIK 0001817716
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 6:28 PM ET
- Size
- 5.9 KB